Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases. | Curr Issues Mol Biol | 2023 | 37504266 | PubTator, text mining | PubMed |
| A pyroptosis-related gene signature that predicts immune infiltration and prognosis in colon cancer. | Front Oncol | 2023 | 37503314 | PubTator, text mining | PubMed |
| Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review. | Heliyon | 2023 | 37496898 | PubTator, text mining | PubMed |
| Identification of inflammatory factor-related genes associated with the prognosis and immune cell infiltration in colorectal cancer patients. | Genes Dis | 2023 | 37492736 | PubTator, text mining | PubMed |
| Differential gene expression analysis combined with molecular dynamics simulation study to elucidate the novel potential biomarker involved in pulmonary TB. | Microb Pathog | 2023 | 37482113 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma. | Pathol Oncol Res | 2023 | 37475874 | PubTator, text mining | PubMed |
| Aged mesenchymal stem cells and inflammation: from pathology to potential therapeutic strategies. | Biol Direct | 2023 | 37464416 | PubTator, text mining | PubMed |
| Influence of type 2 diabetes and obesity on adipose mesenchymal stem/stromal cell immunoregulation. | Cell Tissue Res | 2023 | 37462786 | PubTator, text mining | PubMed |
| Targeting endometrial inflammation in intrauterine adhesion ameliorates endometrial fibrosis by priming MSCs to secrete C1INH. | iScience | 2023 | 37456855 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cells and Exosomes: A Novel Therapeutic Approach for Corneal Diseases. | Int J Mol Sci | 2023 | 37446091 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell Conditioned Medium Modulates Inflammation in Tenocytes: Complete Conditioned Medium Has Superior Therapeutic Efficacy than Its Extracellular Vesicle Fraction. | Int J Mol Sci | 2023 | 37446034 | PubTator, text mining | PubMed |
| Two Amnion-Derived Mesenchymal Stem-Cells Injections to Osteoarthritic Elbows in Dogs-Pilot Study. | Animals (Basel) | 2023 | 37443993 | PubTator, text mining | PubMed |
| Gene expression of peripheral blood mononuclear cells and CD8+ T cells from gilts after PRRSV infection. | Front Immunol | 2023 | 37409113 | PubTator, text mining | PubMed |
| The inflammatory oxidant peroxynitrous acid modulates the structure and function of the recombinant human V3 isoform of the extracellular matrix proteoglycan versican. | Redox Biol | 2023 | 37402332 | PubTator, text mining | PubMed |
| Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment. | Cell Transplant | 2023 | 37395459 | PubTator, text mining | PubMed |
| Monocyte adhesive hyaluronan matrix induced by hyperglycemia in diabetic lung injuries. | J Biol Chem | 2023 | 37394007 | PubTator, text mining | PubMed |
| Exploratory genome-wide analyses of cortical inhibition, facilitation, and plasticity in late-life depression. | Transl Psychiatry | 2023 | 37391420 | PubTator, text mining | PubMed |
| TSG6 hyaluronan matrix remodeling dampens the inflammatory response during colitis. | Matrix Biol | 2023 | 37391162 | PubTator, text mining | PubMed |
| Applications of Bioinspired Platforms for Enhancing Immunomodulatory Function of Mesenchymal Stromal Cells. | Int J Stem Cells | 2023 | 37385634 | PubTator, text mining | PubMed |
| CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer. | Cancer Res | 2023 | 37379438 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=16